Aigen Investment Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$210K Buy
24,765
+13,613
+122% +$90.6K 0.06% 427
2026
Q1
$60.8K Buy
+11,152
New +$62.6K 0.02% 485
2025
Q1
– Sell
-20,452
Closed -$186K – 1026
2024
Q4
$186K Buy
+20,452
New +$197K 0.03% 619
2023
Q4
– Sell
-16,042
Closed -$298K – 1076
2023
Q3
$298K Buy
+16,042
New +$374K 0.06% 525
2023
Q2
– Sell
-27,015
Closed -$700K – 959
2023
Q1
$700K Buy
+27,015
New +$723K 0.1% 252
2022
Q4
– Sell
-8,467
Closed -$215K – 769
2022
Q3
$215K Buy
+8,467
New +$297K 0.03% 498
2022
Q2
– Sell
-4,878
Closed -$352K – 718
2022
Q1
$352K Sell
4,878
-16,416
-77% -$1.18M 0.06% 339
2021
Q4
$2.01M Buy
+21,294
New +$2.55M 0.12% 215
2020
Q3
– Sell
-3,089
Closed -$590K – 1102
2020
Q2
$590K Buy
+3,089
New +$541K 0.08% 414
2020
Q1
– Sell
-990
Closed -$83K – 1560
2019
Q4
$83K Buy
+990
New +$75.3K 0.01% 723

Other funds holding TDOC

Aigen Investment Management's TDOC Position: Q2 2026 in Review

Aigen Investment Management increased its Teladoc Health (TDOC) stake by 122% in Q2 2026, buying an estimated $90.6K and bringing the position to 24,765 shares worth $210K. The position accounts for 0.06% of the portfolio, ranked #427.

Aigen Investment Management first reported a position in TDOC in Q4 2019 and has held it in 10 quarters since. The position peaked at $2.01M in Q4 2021. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Aigen Investment Management held 24,765 shares of Teladoc Health worth $210K as of Q2 2026.
  • Aigen Investment Management bought 13,613 Teladoc Health shares in Q2 2026, an estimated $90.6K.
  • Teladoc Health made up 0.06% of Aigen Investment Management's portfolio in Q2 2026, its #427 holding.
  • Aigen Investment Management first reported a position in Teladoc Health in Q4 2019 and has held it in 10 quarters since.
  • Aigen Investment Management's Teladoc Health position peaked at $2.01M in Q4 2021.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.